Reposted by Chiara FalcomatàNature Reviews Cancer @natrevcancer.nature.com · 16/01/2026dlvr.itHeterocellular crosstalk and architecture of the pancreatic tumour microenvironmentNature Reviews Cancer, Published online: 16 January 2026; doi:10.1038/s41568-025-00905-9Pancreatic ductal adenocarcinoma is defined by a fibroinflammatory microenvironment, which influences both disease progression and therapy response. In this Review, Arnold et al. outline our current understanding of the complex interplay between the stromal elements of the tumour microenvironment in pancreatic ductal adenocarcinoma and present ways we might use this knowledge to develop better therapeutic strategies for patients with pancreatic cancer. 0149
Reposted by Chiara FalcomatàBrownLab @Mt.Sinai @brownlab1.bsky.social · 17/10/2025Our new review in @natbiomedeng.nature.com is out! RNA-loaded lipid nanoparticles (LNPs) have huge potential—but their strong liver and immune cell uptake has mostly confined them to vaccines and liver therapies. We explore how to move beyond those limits. free to read 🔗 rdcu.be/eLxGsrdcu.beTargeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein levelNature Biomedical Engineering - This Review explores strategies for targeting and tracking RNA-LNP drugs, monitoring their in vivo behaviour, enhancing tissue-specific delivery, and using synthetic... 13511
Chiara Falcomatà @chiarafalcomata.bsky.social · 18/06/2025🚨 Our new #preprint is out! doi.org/10.1101/2025... We used #PerturbMap spatial functional genomics in pancreatic cancer to track tumor clone dynamics and uncover how extracellular factors like Serpine1 and Serpinb2 drive immune evasion. 🧵 (1/8)doi.org 2147
Reposted by Chiara Falcomatàverat-h.bsky.social @verat-h.bsky.social · 18/02/2025Thrilled to share that our work from Trumpp Lab @hi-stem @dkfz.bsky.social is out in Nature. We provide the first single-cell data on neurons infiltrating pancreatic tumors, offering new insights into cancer therapy. #cancerneuroscience @cn-hd.bsky.social www.nature.com/articles/s41... 25120
Reposted by Chiara FalcomatàSinai Immuno @sinaiimmuno.bsky.social · 28/01/2025Immunology will be for everyone, everywhere, everyday, from driving foundational research to reaping the benefits for health. 🌎 Immunoschool 2025 is open for anyone looking to learn more about key immunotherapy advances over the last decade. FREE TO REGISTER: www.eventbrite.com/e/internatio...eventbrite.comInternational Course of Immunotherapy March 10-12, 2025Eventbrite - Precision Immunology Institute at the Icahn School of Medicine presents International Course of Immunotherapy March 10-12, 2025 - Monday, March 10, 2025 | Wednesday, March 12, 2025 - Find... 13320
Reposted by Chiara FalcomatàJohanna Joyce @johannajoyce.bsky.social · 06/02/2025The incidence of early-onset colorectal #cancer is surging By 2030, 1/3 of all CRCs will occur before the typical recommended screening age of 50 years In this #Cell commentary, Mauri et al. discuss the potential causes 🧪- and the importance of determining "tumor age" www.cell.com/cell/fulltex... 13410
Reposted by Chiara FalcomatàBrownLab @Mt.Sinai @brownlab1.bsky.social · 15/01/2025First lab Bluesky post! Happy to share new papers: PRINT: Using Perturb-map, we show in @cellpress.bsky.social how ovarian tumors resist immunotherapy > www.cell.com/cell/abstrac... PREPRINT We developed a new technology to easily generate cell-targeted LNP-RNA > www.biorxiv.org/content/10.1...cell.comOvarian cancer-derived IL-4 promotes immunotherapy resistanceCancer-derived paracrine factors create distinct “neighborhoods” in the tumor microenvironment, promoting clonal selection and tumor heterogeneity. In ovarian cancer, IL-4 originating from a minority ... 0139
Reposted by Chiara FalcomatàAris Papargyriou @arispapargyriou.bsky.social · 10/12/2024I am so excited to share the biggest (and best) part of my #PhD in @maxreichertmd.bsky.social lab We show how inter/intra-tumoral #heterogeneity impacts plasticity and treatment resistance by using #PDAC #organoids @natureportfolio.bsky.social www.nature.com/articles/s41...nature.comHeterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma - Nature Biomedical EngineeringBranched organoids embedded in collagen gels can recapitulate the phenotypic landscape and pronounced molecular and morphological heterogeneity of pancreatic ductal adenocarcinoma. 66011
Reposted by Chiara FalcomatàAnna Obenauf @obenaufa.bsky.social · 27/11/20241/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41... 47559142
Reposted by Chiara FalcomatàIvan Zanoni @lozanzi.bsky.social · 27/11/2024#InterferonPower! Elewaut, @obenaufa.bsky.social &co show @ Nature that inflammatory monocytes can acquire MHC-class I from tumor cells & locally activate CD8 T cells, given that the capacity of the tumor to shut down type I #IFNs & upreg PGE2 is reverted! www.nature.com/articles/s41...nature.comCancer cells impair monocyte-mediated T cell stimulation to evade immunity - NatureInflammatory monocytes are identified as important players in T cell restimulation in the tumour microenvironment. 15710
Reposted by Chiara FalcomatàAnirban Maitra @anirbanmaitra.bsky.social · 23/11/2024#PancreaticCancer research starter pack. 65 of 150. Room for 85 more on this 1st starter pack. Who did I miss? go.bsky.app/FDafAW 419738